ESMO Breast Cancer 2023 Congress Coverage
ESMO Breast Cancer 2023 EMERALD Trial: Analysis of PROs in Patients With ER+/HER2- Advanced or Metastatic BC Comparing Oral Elacestrant vs. Standard of Care ET
By
ESMO Breast Cancer 2023 Congress Coverage
FEATURING
Javier Cortes
By
ESMO Breast Cancer 2023 Congress Coverage
FEATURING
Javier Cortes
Login to view comments.
Click here to Login
